• Homepage
• Company
• News
• Products
  • CHIRAL HPLC & SFC columns
    • Immobilised CHIRALPAK®
    • CHIRALPAK® & CHIRALCEL®
    • Reverse phase columns
    • Special application columns
    • Preparative columns & bulk CSPs
      • CHIRALPAK® IA
      • CHIRALPAK® IC
      • CHIRALCEL® OD-I
      • CHIRALPAK® AD
      • CHIRALPAK® AS-V
      • CHIRALCEL® OD
      • CHIRALCEL® OJ
      • CHIRALPAK® AY
      • CHIRALPAK® AZ
      • CHIRALCEL® OZ
      • Other Chiral Stationary Phases
  • CHROMTECH HPLC columns
    • CHIRAL AGP
    • CHIRAL CBH
    • CHIRAL HSA
  • Bio-catalysis
• Method development service
• Custom separation service
  • Small-scale separation
  • Medium-scale separation
  • Large-scale separation
  • cGMP
  • Drug Master File cGMP
• Applications
  • QC and chiral separation
  • Chiral separation for R&D screening
  • Scale-up of chiral separation
• Technical support
  • Download catalogue
  • Application guide
  • FAQ
• Contact

News & informations

New Laboratory of CHIRAL TECHNOLOGIES EUROPE - ( 29/09/2009)

Illkirch, FRANCE, September 29, 2009. CHIRAL TECHNOLOGIES EUROPE is pleased to announce that our new Chiral Separations Laboratory is now operational.

Since 1995 Chiral Technologies Europe (CTE) has offered a contract chiral separation service which utilised HPLC and Simulated Moving Bed (SMB) technology to separate 10 g to 100 kg quantities at our laboratories in Illkirch (near Strasbourg) France. From 2006 we additionally offered to rapidly screen and separate smaller quantities of chiral pharmaceutical molecules. This service utilises HPLC and Super Critical Fluid chromatography to separate mg to multi g samples.

Since 2006 our laboratories have separated an increasing number of samples for Biotechnology, Pharmaceutical, Agrochemical and Flavour/Fragrance companies. The combination of a fast free screen, high yield, high specification and low cost has resulted in this approach being the route of preference to obtain initial quantities of both chiral isomers for toxicological and early biological studies. In 2008 our capacity to separate compounds was nearing exhaustion. Hence we have designed and commissioned a new laboratory specific to the needs of custom small scale chiral separations.

Our new laboratory was commissioned on the first of August 2009 and is now operational and is separating compounds for biotechnology and pharmaceutical companies across Europe.